ArticleMycopathologia2016
Challenges in Fusarium, a Trans-Kingdom Pathogen.
Article in Mycopathologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 55 citations in OpenAlex.
- Antimicrobial Potential of Defensin-DerivedInternational journal of molecular sciences · 2026Article
- Successful treatment of 40-year chronic auricular cutaneous infection caused by multidrug-resistantMedical mycology case reports · 2026Article
- A Sensitive Real-Time PCR-Based Assay for the Identification ofJournal of fungi (Basel, Switzerland) · 2026Article
- Facultative heterochromatin mediated by core and accessory chromosome-encoded H3K27-specific methyltransferases controls virulence in a fungal phytopathogen.Nucleic acids research · 2026Article
- Antifungal and fungicide susceptibility of clinical, animal, and environmental Fusarium and Neocosmospora species from Colombia: a one-health approach.Scientific reports · 2025Article
- Prevalence and diversity of antifungal resistance inAntimicrobial agents and chemotherapy · 2025Article
- Olorofim activity against multidrug-resistantAntimicrobial agents and chemotherapy · 2025Article
- Article
- The Dual PathogenJournal of fungi (Basel, Switzerland) · 2025Review
- Microbial Community Structure and Diversity of Endophytic Bacteria and Fungi in the Healthy and Diseased Roots ofMicroorganisms · 2025Article
- Biofilm Formation in Clinical Isolates ofJournal of fungi (Basel, Switzerland) · 2024Article
- Phylogenomic approaches reveal a robust time-scale phylogeny of the Terminal Fusarium Clade.IMA fungus · 2024Article
- Fusarioid keratitis and other superficial infections: A 10-years prospective study from Northeastern Brazil.PLoS neglected tropical diseases · 2024Article
- Molecular identification of Brazilian Fusarium strains: sources of proteases with milk-clotting properties.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
- MALDI-TOF MS: A Quick Method to Detect the Susceptibility ofMicroorganisms · 2023Article
- Simulated Microgravity Created Using a Random Positioning Machine Induces Changes in the Physiology of theMicroorganisms · 2022Article
- Study on the anti-biofilm mechanism of 1,8-cineole againstFrontiers in pharmacology · 2022Article
- Comparison of molecular and MALDI-TOF MS identification and antifungal susceptibility of clinicalFrontiers in microbiology · 2022Article
- Keystone TaxaMicroorganisms · 2021Article
- A One Health Perspective to RecognizeJournal of fungi (Basel, Switzerland) · 2020Review
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium species are emerging human pathogens, next to being plant pathogens. Problems with Fusarium are in their diagnostics and in their difficult treatment, but also in what are actual Fusarium species or rather Fusarium-like species. In this issue Guevara-Suarez et al. (Mycopathologia. doi: 10.1007/s11046-016-9983-9 , 2016) characterized 89 isolates of Fusarium from Colombia showing especially lineages within the Fusarium solani and oxysporum species complexes to be responsible for onychomycosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.